New R&D Center

INFA GROUP, Italian API manufacturer since 1953, opened a new state of the art R&D Center in one of its two Italian manufacturing units SIFAVITOR.
The structure hosts a highly skilled and qualified team of scientists dedicated to the Generic Pipeline of the Group that counts today more than 20 active projects while working in close cooperation with three Italian Chemistry Universities and the Italian Biocatalysis Center (IBC),
Specific focus is given to the respiratory area with ongoing progress on the development of Indacaterol, Vilanterol and Umeclidinium. The target being to maximize the synergies with Labochim, the other Italian plant in the Group where during Q1/2015 a specific HP API Plant was inaugurated for these types of molecules and this moment, in final stage of validation of Tiotropium Bromide.
We are extremely pleased with this new important milestone in our growth trajectory, commented Chairman of the Group, Daniele Cardoso, and grateful to our R&D Team for its outstanding performance allowing INFA Group to file a record number of patents (9) in the first half of 2015! This again, confirms the full commitment of INFA Group to continue to supply the Generic Market with innovative products.